In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Protein Therapeutics Inc.

Latest From Protein Therapeutics Inc.

Protein Therapeutics Inc.

A major problem in treating rheumatoid arthritis is that current drugs cause numerous, often serious, side effects. Protein Therapeutics Inc. has developed an oral formulation of human gammaglobulin (higG) that may effectively treat rheumatoid arthritis without side effects.

BioPharmaceutical
See All

Company Information

UsernamePublicRestriction

Register